Document is current
Any future updates will be listed below
-
Authors
Tümmler, Burkhard
Pallenberg, Sophia Theres
Dittrich, Anna-Maria
Graeber, Simon Y.
Naehrlich, Lutz
Sommerburg, Olaf
Mall, Marcus A.
-
Funding
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
- License Information
-
More Information
Article History
Received: 20 January 2025
Accepted: 3 April 2025
First Online: 5 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: B.T. reports grants and contracts from the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF) and the Volkswagen Stiftung with payments made to the institution; personal fees for advisory board participation and educational events from Vertex Pharmaceuticals; lecture honoraria from Vertex Pharmaceuticals and streamedup! GmbH. S.T.P. reports grants and contracts from the Mukoviszidose e.V., the Else Kröner Fresenius Foundation and the Deutsche Forschungsgemeinschaft (DFG) with payments made to the institution and travel support from Vertex Pharmaceuticals. A-M.D. reports grants and contracts from the German Federal Ministry of Education and Research (BMBF), Vertex Pharmaceuticals Incorporated, European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) and Christiane Herzog Stiftung with payments made to the institution, personal fees from the c4c consortium, GSK and European Cystic Fibrosis Society.S.Y.G. reports grants from Mukoviszidose e.V. (German CF Foundation) and Vertex Pharmaceuticals Incorporated with payments made to institution; personal fees for advisory board participation from Chiesi GmbH and Vertex Pharmaceuticals Incorporated; lecture honoraria and honoraria for a CME module from Vertex Pharmaceuticals Incorporated. L.N. reports grants and contracts from the German Federal Ministry of Education and Research (BMBF), the European Cystic Fibrosis Society and Vertex Pharmaceuticals with payments made to the institution. O. S. reports grants from the German Federal Ministry of Education and Research (BMBF) with payment made to the institution and honoraria from Vertex Pharmaceuticals Incorporated for lectures.M.A.M. reports grants and contracts from the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF), Boehringer Ingelheim, Enterprise Therapeutics and Vertex Pharmaceuticals with payments made to the institution; personal fees for advisory board participation or consulting from Boehringer Ingelheim, Enterprise Therapeutics, Kither Biotech, Splisense, Vertex Pharmaceuticals; lecture honoraria from Vertex Pharmaceuticals; and travel support from Boehringer Ingelheim and Vertex Pharmaceuticals.
